Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?

被引:12
|
作者
Solomon, James P.
Lowenthal, Brett M.
Kader, A. Karim
Parsons, J. Kellogg
Flaig, Thomas W.
Siefker-Radtke, Arlene O.
Dyrskjot, Lars
Hansel, Donna E.
机构
[1] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Dept Urol, San Diego, CA 92103 USA
[3] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO USA
[4] UTMD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX USA
[5] Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark
关键词
TRANSITIONAL-CELL-CARCINOMA; INVASIVE MICROPAPILLARY CARCINOMA; LYMPHOEPITHELIOMA-LIKE CARCINOMA; MATCHED COHORT ANALYSIS; URINARY-BLADDER; RADICAL CYSTECTOMY; CLINICOPATHOLOGICAL ANALYSIS; NEOADJUVANT CHEMOTHERAPY; CLINICAL-OUTCOMES; LUMINAL SUBTYPES;
D O I
10.1016/j.urology.2016.10.014
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Urothelial carcinoma can exhibit a wide variety of histopathologic phenotypes or variant morphologies, classifications of which have recently been revised in the 2016 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs. Many of these variants not only present diagnostic challenges, but also have clinical implications that affect patient prognosis and treatment strategies. This review will discuss these variant morphologies and their relationship to current understanding of the underlying biology of urothelial carcinoma and molecular classification paradigms. (C) 2016 Elsevier Inc.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [1] Molecular Pathology of Urothelial Carcinoma
    Al-Ahmadie, Hikmat
    Netto, George J.
    [J]. CLINICS IN LABORATORY MEDICINE, 2024, 44 (02) : 181 - 198
  • [2] Molecular pathology of urothelial carcinoma
    Lopez-Beltran, Antonio
    Cimadamore, Alessia
    Montironi, Rodolfo
    Cheng, Liang
    [J]. HUMAN PATHOLOGY, 2021, 113 : 67 - 83
  • [3] Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance
    Mahlow, Jonathon
    Gupta, Sumati
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (07) : 193 - 202
  • [4] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma
    Miyake, Makito
    Owari, Takuya
    Hori, Shunta
    Nakai, Yasushi
    Fujimoto, Kiyohide
    [J]. RESEARCH AND REPORTS IN UROLOGY, 2018, 10 : 251 - 261
  • [5] Durvalumab for the management of urothelial carcinoma: a short review on the emerging data and therapeutic potential
    Baldini, Capucine
    Champiat, Stephane
    Vuagnat, Perrine
    Massard, Christophe
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 2505 - 2512
  • [6] Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications
    Lopez-Beltran, Antonio
    Cheng, Liang
    [J]. HUMAN PATHOLOGY, 2006, 37 (11) : 1371 - 1388
  • [7] Colorectal carcinoma as an example of molecular cancer predisposition diagnosis - What can pathology contribute?
    Ruschoff, J
    Dietmaier, W
    Bocker, T
    Wallinger, S
    Kullmann, F
    Behman, A
    Hofstadter, F
    [J]. PATHOLOGE, 1998, 19 (04): : 269 - 278
  • [8] Next Generation Digital Pathology: Emerging Trends and Measurement Challenges for Molecular Pathology
    Dexter, Alex
    Tsikritsis, Dimitrios
    Belsey, Natalie A.
    Thomas, Spencer A.
    Venton, Jenny
    Bunch, Josephine
    Romanchikova, Marina
    [J]. JOURNAL OF MOLECULAR PATHOLOGY, 2022, 3 (03): : 168 - 181
  • [9] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
    Bolenz, Christian
    Lotan, Yair
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (12): : 676 - 685
  • [10] Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use
    Christian Bolenz
    Yair Lotan
    [J]. Nature Clinical Practice Urology, 2008, 5 : 676 - 685